较低的社会经济地位可能有助于解释喘和亚托邦皮肤炎患病率的种族差异:调解分析
Emily A Croce1, Layla Parast2, Darlene Bhavnani3
1Dell Medical School, University of Texas at Austin, Austin, Tex; Steve Hicks School of Social Work, University of Texas at Austin, Austin, Tex; Dell Children's Medical Group, Austin, Tex.
The Journal of allergy and clinical immunology
|November 23, 2023
概括
黑人儿童比白人儿童患上阿托皮炎 (AD) 和喘的比例更高. 社会经济因素解释了这些种族差异的很大一部分在儿童的亚托皮性疾病.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 儿科 儿科 儿科
背景情况:
- 种族差异在亚托邦性疾病 (亚托邦性皮肤炎,喘,过敏) 的患病率上是有记录的.
- 社会经济地位 (SES) 与无形性疾病有关,但其在解释种族差异方面的作用尚不清楚.
研究的目的:
- 为了识别儿童亚托皮性疾病患病率的种族差异.
- 确定SES在多大程度上调解这些种族差异.
主要方法:
- 利用了国家健康访谈调查数据 (2011-2018).
- 在黑人和白人儿童中调查了亚托皮炎,喘和呼吸道过敏的流行率.
- 评估了由社会经济地位指标解释的差异比例.
主要成果:
- 与白人儿童相比,黑人儿童患上亚托邦性皮炎 (17.4%) 和喘 (14.3%) 的患病率较高 (分别为11.8%和7.4%).
- 黑人 (10.9%) 和白人 (11.4%) 儿童的呼吸道过敏患病率相似.
- 黑人和白人儿童之间的社会经济地位解释了亚托皮炎的25%和喘的47%的差异.
结论:
- 黑人儿童比白人儿童患上亚托邦性皮炎和喘的比例更高.
- 社会经济地位显著调解了种族与亚托皮性皮肤炎和儿童喘患病率之间的关联.
- 调查结果突出了美国种族,社会经济因素和亚托皮性疾病的复杂相互作用.
相关概念视频
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management
412
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
412
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
307
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
307
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Drugs Used in Lower Respiratory Disorders: Overview
452
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
452


